Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis

OBJECTIVE: To assess the safety and efficacy of lenabasum in diffuse cutaneous systemic sclerosis (dcSSc). METHODS: A randomized, double‐blind, placebo‐controlled, phase II study was conducted at 9 SSc clinics in the US. Adults with dcSSc of ≤6 years’ duration who were receiving stable standard‐of‐c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Rheumatol
Main Authors: Spiera, Robert, Hummers, Laura, Chung, Lorinda, Frech, Tracy M., Domsic, Robyn, Hsu, Vivien, Furst, Daniel E., Gordon, Jessica, Mayes, Maureen, Simms, Robert, Lafyatis, Robert, Martyanov, Viktor, Wood, Tammara, Whitfield, Michael L., Constantine, Scott, Lee, Elizabeth, Dgetluck, Nancy, White, Barbara
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Systemic Sclerosis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497006/
https://ncbi.nlm.nih.gov/pubmed/32336038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41294
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares